CT

Cytek Biosciences Inc. Common Stock Earnings Recaps

CTKB Health Care 2 recaps
Next earnings: November 4, 2026 (estimated) · full calendar
Q2 2026 Aug 7, 2026

Shares declined 2.8% after the Q2 report, reflecting investor caution despite steady revenue growth, with margin pressures and weakness in EMEA likely weighing on sentiment.

Key takeaways
  • Q2 revenue grew 6% year-over-year to $48.1 million, driven by double-digit growth in U.S. and China markets.
  • U.S. revenue increased 18% to $28.2 million, supported by gains in academic and government sectors and service business.
  • EMEA revenue declined approximately 8% year-over-year, impacted by ongoing regional budgetary constraints.
  • Total APAC revenue was flat, with strong growth in China offset by softness elsewhere in the region.
  • Recurring revenue from reagents and services rose 8% to $18.5 million, now 35% of trailing twelve-month revenue, up from 32% a year ago.
Full recap
Q1 2026 May 8, 2026

Shares of Cytek Biosciences declined 6.7% after the company’s Q1 results failed to fully reassure investors, primarily due to revenue deceleration in key regions, a cautious outlook, and shipment delays that pressured growth outside the U.S.

Key takeaways
  • Total Q1 revenue grew 6% year-over-year to $44.1 million but was weighed down by a 7% revenue decline in EMEA and a 13% drop in APAC including China.
  • U.S. revenue was a bright spot with a 32% increase to $24.4 million, driven by repeat sales to academic and biopharma customers and continued adoption of Aurora flagship instruments.
  • Recurring revenue (service and reagents) reached $18.4 million on a trailing 12-month basis, representing 35% of total revenue and growing 19% year-over-year.
  • Instrument unit volume rose 9% year-over-year, aided by solid uptake of the Aurora Evo system, which contributed 8% revenue growth in the analyzer category.
  • EMEA softness arose from Middle East conflict disruptions and end-of-quarter shipment delays, while APAC weakness reflected tough prior-year comparisons and timing shifts in China orders.
Full recap

Go deeper on CTKB and the wider market.

All earnings recaps Browse the latest results across the market. Stock directory Browse companies by sector and market. Highest-yield stocks A curated screen of top dividend payers. Investing glossary Plain-English definitions for every metric.